Albert Benjamin 4

What Happened Albert Benjamin, CEO and Director of Health Catalyst, disposed of 336 shares on 2026-06-01 at $1.37 per share for proceeds reported as $460. This was a sale required to cover tax withholding tied to the vesting of restricted stock units, not a discretionary open-market sale.

Key Details

• Transaction date & price: 2026-06-01 at $1.37 per share (336 shares, ~$460 proceeds).
• Shares owned after transaction: Not stated in the provided filing.
• Footnote: The sale was a mandatory "sell-to-cover" to satisfy tax withholding on RSU vesting (see F1). This does not reflect a voluntary trade decision by the insider.
• Filing timeliness: Report filed 2026-06-03 for a 2026-06-01 transaction — appears to be filed within the typical two-business-day Form 4 window.

Context Sell-to-cover transactions are routine administrative actions when equity awards vest; they generally do not signal insider sentiment about the company. For investors, purchases are typically more informative than mandatory sales for tax withholding.